Galecto, Inc. (GLTO) Financials
GLTO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 38.2 million | 5.9 million |
2023-09-30 | 50.0 million | 12.7 million |
2023-06-30 | 58.8 million | 15.1 million |
2023-03-31 | 64.6 million | 14.3 million |
GLTO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -11.5 million | 1.1 million |
2023-09-30 | -8.5 million | 1.5 million |
2023-06-30 | -7.8 million | 1.4 million |
2023-03-31 | -9.1 million | 1.4 million |
GLTO Net Income
No data available :(
GLTO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 33.2 million | - | 249000 |
2023-09-30 | 44.2 million | - | 464000 |
2023-06-30 | 52.1 million | - | 626000 |
2023-03-31 | 53.2 million | - | 686000 |
GLTO Shares Outstanding
GLTO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 2.8 million | 3.2 million | 229000 |
2023-09-30 | - | 2.6 million | 3.3 million | - |
2023-06-30 | - | 8.1 million | 3.1 million | - |
2023-03-31 | - | 10.4 million | 3.1 million | - |
GLTO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.2 million | 229000 |
2023-09-30 | - | 367000 |
2023-06-30 | - | 95000 |
2023-03-31 | - | 139000 |
GLTO
Price: $0.72
52 week price:
Earnings Per Share: -1.44 USD
P/E Ratio: -0.38
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 27417
Market Capitalization: 18.6 million